EE200200281A - Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks - Google Patents
Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiksInfo
- Publication number
- EE200200281A EE200200281A EEP200200281A EEP200200281A EE200200281A EE 200200281 A EE200200281 A EE 200200281A EE P200200281 A EEP200200281 A EE P200200281A EE P200200281 A EEP200200281 A EE P200200281A EE 200200281 A EE200200281 A EE 200200281A
- Authority
- EE
- Estonia
- Prior art keywords
- compositions
- pharmaceutical uses
- synthesis agents
- picornavirus
- compounds
- Prior art date
Links
- 230000001556 anti-picornavirus Effects 0.000 title 1
- 230000015572 biosynthetic process Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000003786 synthesis reaction Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16898699P | 1999-12-03 | 1999-12-03 | |
| US19205200P | 2000-03-24 | 2000-03-24 | |
| PCT/US2000/032621 WO2001040189A1 (fr) | 1999-12-03 | 2000-12-01 | Composes et compositions anti-picornavirus; utilisations pharmaceutiques et materiaux employes pour leur synthese |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200200281A true EE200200281A (et) | 2003-06-16 |
Family
ID=26864652
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200200281A EE200200281A (et) | 1999-12-03 | 2000-12-01 | Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US6514997B2 (fr) |
| EP (1) | EP1252145A1 (fr) |
| JP (1) | JP2003515591A (fr) |
| KR (1) | KR20020058076A (fr) |
| CN (1) | CN1402710A (fr) |
| AP (1) | AP2002002510A0 (fr) |
| AR (1) | AR030540A1 (fr) |
| AU (1) | AU777943B2 (fr) |
| BG (1) | BG106754A (fr) |
| BR (1) | BR0016742A (fr) |
| CA (1) | CA2392504A1 (fr) |
| CO (1) | CO5261566A1 (fr) |
| CZ (1) | CZ20021906A3 (fr) |
| DO (1) | DOP2000000108A (fr) |
| EA (1) | EA200200625A1 (fr) |
| EE (1) | EE200200281A (fr) |
| HK (1) | HK1052933A1 (fr) |
| HU (1) | HUP0204006A3 (fr) |
| IL (1) | IL149427A0 (fr) |
| IS (1) | IS6378A (fr) |
| MX (1) | MXPA02005124A (fr) |
| NO (1) | NO20022589L (fr) |
| NZ (1) | NZ518934A (fr) |
| OA (1) | OA12101A (fr) |
| PA (1) | PA8507801A1 (fr) |
| PE (1) | PE20020157A1 (fr) |
| PL (1) | PL356062A1 (fr) |
| SK (1) | SK7602002A3 (fr) |
| UY (1) | UY26465A1 (fr) |
| WO (1) | WO2001040189A1 (fr) |
| YU (1) | YU40002A (fr) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA003856B1 (ru) | 1998-04-30 | 2003-10-30 | Агурон Фармасьютикалз, Инк. | Антипикорнавирусные композиции, их получение и применение |
| PA8515201A1 (es) | 2000-04-14 | 2002-10-24 | Agouron Pharma | Compuestos y composiciones antipicornavirales; sus usos farmaceuticos y los materiales para su sintesis |
| JP2004503533A (ja) * | 2000-06-14 | 2004-02-05 | アグロン・ファーマシュウティカルズ・インコーポレーテッド | 抗ピコルナウイルス化合物及び組成物、その医薬的使用、並びにその合成のための物質 |
| ATE438624T1 (de) * | 2000-12-28 | 2009-08-15 | Shionogi & Co | 2-pyridonderivate mit affinität für den cannabinoid-typ-2-rezeptor |
| EP1523483A4 (fr) | 2002-06-26 | 2006-03-08 | Bristol Myers Squibb Co | Pyrazinones amino-bicycliques et pyridinones utilisees comme inhibiteurs de coagulation de la serine protease |
| EP1606019A1 (fr) * | 2003-03-07 | 2005-12-21 | The University Court of The University of Aberdeen | Agonistes inverses de recepteurs de cannabinoides et antagonistes neutres agissant en tant qu'agents therapeutiques destines au traitement de troubles osseux |
| WO2004093860A1 (fr) * | 2003-04-21 | 2004-11-04 | Pfizer Inc. | Inhibiteurs de proteinase de coronavirus apparente au virus du sras |
| US20040235952A1 (en) * | 2003-05-05 | 2004-11-25 | Agouron Pharmaceuticals, Inc. | Inhibitors of severe acute respiratory syndrome (SARS) 3C-like proteinase |
| CA2550515A1 (fr) * | 2003-12-31 | 2005-07-21 | Taigen Biotechnology | Inhibiteurs de la protease |
| US7462594B2 (en) * | 2003-12-31 | 2008-12-09 | Taigen Biotechnology Co., Ltd. | Peptide-like compounds that inhibit coronaviral 3CL and flaviviridae viral proteases |
| US7087622B2 (en) | 2004-05-07 | 2006-08-08 | Janssen Pharmaceutica N.V. | Pyridone compounds as inhibitors of bacterial type III protein secreation systems |
| GB0702862D0 (en) * | 2007-02-14 | 2007-03-28 | Univ Aberdeen | Therapeutic compounds |
| KR100891699B1 (ko) | 2007-04-10 | 2009-04-03 | 광주과학기술원 | 7-아미노-4-((ｓ)-3-(4-플루오로페닐)-2-((r)-3-메틸-2-(5-메틸이소옥사졸-3-카복사미도)부탄아미도)프로판아미도)-7-옥소-2-헵테노에이트 유도체, 이의 제조방법 및 이를 유효성분으로 함유하는 바이러스성 질환의 예방 및 치료용 약학적 조성물 |
| EP2320891B1 (fr) * | 2008-08-29 | 2013-10-09 | Treventis Corporation | Ligands de la butyrylcholinestérase en tant qu'outils de diagnostic et de traitement des pathologies du système nerveux |
| KR101385855B1 (ko) * | 2012-10-16 | 2014-04-22 | 이동익 | 카뎁신 검출용 다이아로마틱 아미노산 기질 |
| EP3455205A4 (fr) * | 2016-05-13 | 2020-01-01 | Emory University | Peptidomimétiques pour le traitement d'une infection à norovirus |
| US11124497B1 (en) | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| JP2023522990A (ja) * | 2020-04-23 | 2023-06-01 | パーデュー・リサーチ・ファウンデーション | Ｓａｒｓの治療のための化合物 |
| US11174231B1 (en) | 2020-06-09 | 2021-11-16 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
| US11351149B2 (en) | 2020-09-03 | 2022-06-07 | Pfizer Inc. | Nitrile-containing antiviral compounds |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4652676A (en) | 1985-05-06 | 1987-03-24 | General Foods Corporation | L-aminodicarboxylic acid alkenes |
| US5374623A (en) | 1992-08-20 | 1994-12-20 | Prototek, Inc. | Cysteine protease inhibitors effective for in vivo use |
| US5514778A (en) | 1993-07-01 | 1996-05-07 | Eli Lilly And Company | Anti-picornaviral agents |
| US5486623A (en) | 1993-12-08 | 1996-01-23 | Prototek, Inc. | Cysteine protease inhibitors containing heterocyclic leaving groups |
| IL112759A0 (en) | 1994-02-25 | 1995-05-26 | Khepri Pharmaceuticals Inc | Novel cysteine protease inhibitors |
| IT1269511B (it) | 1994-05-17 | 1997-04-01 | Univ Degli Studi Milano | Derivati di acidi ammino-solfonici , loro impiego nella sintesi di pseudopeptidi e procedimento per la loro preparazione |
| US5498616A (en) | 1994-11-04 | 1996-03-12 | Cephalon, Inc. | Cysteine protease and serine protease inhibitors |
| WO1996030395A2 (fr) | 1995-03-31 | 1996-10-03 | Takeda Chemical Industries, Ltd. | Inhibiteur de la protease de cysteine |
| IT1281031B1 (it) | 1995-11-17 | 1998-02-11 | Carlo Chiaves | Struttura prefabbricata per la realizzazione di opere costruite a cielo aperto, particolarmente per cavalcavia autostradali, |
| DE69733137T2 (de) | 1996-05-14 | 2006-03-02 | Agouron Pharmaceuticals, Inc., San Diego | Inhibitoren von picornavirus 3c protease und verfahren zur herstellung und verwendung |
| US5856530A (en) | 1996-05-14 | 1999-01-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| WO1997049668A1 (fr) | 1996-06-13 | 1997-12-31 | Smithkline Beecham Corporation | Inhibiteurs de cysteine protease |
| US6020371A (en) | 1997-03-28 | 2000-02-01 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds compositions containing them and methods for their use |
| PT975588E (pt) * | 1997-03-28 | 2004-02-27 | Agouron Pharma | Compostos antipicornavirais, composicoes que os contem e metodos para a sua utilizacao |
| US6331554B1 (en) | 1997-03-28 | 2001-12-18 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds, compositions containing them, and methods for their use |
| US5962487A (en) | 1997-12-16 | 1999-10-05 | Agouron Pharmaceuticals, Inc. | Antipicornaviral compounds and methods for their use and preparation |
| EA003856B1 (ru) * | 1998-04-30 | 2003-10-30 | Агурон Фармасьютикалз, Инк. | Антипикорнавирусные композиции, их получение и применение |
| US6369226B1 (en) | 1999-06-21 | 2002-04-09 | Agouron Pharmaceuticals, Inc. | Substituted benzamide inhibitors of rhinovirus 3C protease |
| DE60014670T2 (de) | 1999-08-04 | 2006-03-09 | Agouron Pharmaceuticals, Inc., San Diego | Antipicornavirale verbindungen und zusammensetzungen, ihre pharmazeutische verwendung, und materialien für ihre synthese |
| IL147862A0 (en) | 1999-08-24 | 2002-08-14 | Agouron Pharma | Process and intermediates for the preparation os isoxazolecaroxamides and analogues |
| PE20010517A1 (es) | 1999-08-24 | 2001-05-16 | Agouron Pharma | Las rutas sinteticas eficientes para la preparacion de los inhibidores de la proteasa del rinovirus y los intermedios claves |
-
2000
- 2000-11-30 PA PA20008507801A patent/PA8507801A1/es unknown
- 2000-11-30 PE PE2000001276A patent/PE20020157A1/es not_active Application Discontinuation
- 2000-12-01 EP EP00980893A patent/EP1252145A1/fr not_active Withdrawn
- 2000-12-01 WO PCT/US2000/032621 patent/WO2001040189A1/fr not_active Ceased
- 2000-12-01 AP APAP/P/2002/002510A patent/AP2002002510A0/en unknown
- 2000-12-01 JP JP2001541874A patent/JP2003515591A/ja not_active Withdrawn
- 2000-12-01 HK HK03104911.5A patent/HK1052933A1/zh unknown
- 2000-12-01 UY UY26465A patent/UY26465A1/es not_active Application Discontinuation
- 2000-12-01 EE EEP200200281A patent/EE200200281A/xx unknown
- 2000-12-01 CZ CZ20021906A patent/CZ20021906A3/cs unknown
- 2000-12-01 AU AU18094/01A patent/AU777943B2/en not_active Ceased
- 2000-12-01 US US09/726,376 patent/US6514997B2/en not_active Expired - Fee Related
- 2000-12-01 DO DO2000000108A patent/DOP2000000108A/es unknown
- 2000-12-01 YU YU40002A patent/YU40002A/sh unknown
- 2000-12-01 IL IL14942700A patent/IL149427A0/xx unknown
- 2000-12-01 NZ NZ518934A patent/NZ518934A/en unknown
- 2000-12-01 KR KR1020027007099A patent/KR20020058076A/ko not_active Withdrawn
- 2000-12-01 OA OA1200200160A patent/OA12101A/en unknown
- 2000-12-01 HU HU0204006A patent/HUP0204006A3/hu unknown
- 2000-12-01 EA EA200200625A patent/EA200200625A1/ru unknown
- 2000-12-01 CA CA002392504A patent/CA2392504A1/fr not_active Abandoned
- 2000-12-01 MX MXPA02005124A patent/MXPA02005124A/es not_active Application Discontinuation
- 2000-12-01 BR BR0016742-8A patent/BR0016742A/pt not_active IP Right Cessation
- 2000-12-01 PL PL00356062A patent/PL356062A1/xx not_active Application Discontinuation
- 2000-12-01 SK SK760-2002A patent/SK7602002A3/sk unknown
- 2000-12-01 CN CN00816602A patent/CN1402710A/zh active Pending
- 2000-12-04 CO CO00092264A patent/CO5261566A1/es not_active Application Discontinuation
- 2000-12-04 AR ARP000106412A patent/AR030540A1/es unknown
-
2002
- 2002-05-10 IS IS6378A patent/IS6378A/is unknown
- 2002-05-30 BG BG106754A patent/BG106754A/bg unknown
- 2002-05-31 NO NO20022589A patent/NO20022589L/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU777943B2 (en) | 2004-11-04 |
| IL149427A0 (en) | 2002-11-10 |
| HUP0204006A3 (en) | 2004-11-29 |
| DOP2000000108A (es) | 2003-03-15 |
| WO2001040189A1 (fr) | 2001-06-07 |
| JP2003515591A (ja) | 2003-05-07 |
| PE20020157A1 (es) | 2002-02-22 |
| UY26465A1 (es) | 2001-06-29 |
| MXPA02005124A (es) | 2003-01-28 |
| KR20020058076A (ko) | 2002-07-12 |
| BR0016742A (pt) | 2002-09-03 |
| NZ518934A (en) | 2003-11-28 |
| US6514997B2 (en) | 2003-02-04 |
| IS6378A (is) | 2002-05-10 |
| NO20022589D0 (no) | 2002-05-31 |
| EA200200625A1 (ru) | 2002-12-26 |
| YU40002A (sh) | 2006-01-16 |
| BG106754A (bg) | 2003-07-31 |
| HUP0204006A2 (hu) | 2003-03-28 |
| CO5261566A1 (es) | 2003-03-31 |
| AR030540A1 (es) | 2003-08-27 |
| HK1052933A1 (zh) | 2003-10-03 |
| PA8507801A1 (es) | 2002-08-26 |
| AP2002002510A0 (en) | 2002-06-30 |
| EP1252145A1 (fr) | 2002-10-30 |
| US20010047006A1 (en) | 2001-11-29 |
| OA12101A (en) | 2006-05-04 |
| PL356062A1 (en) | 2004-06-14 |
| AU1809401A (en) | 2001-06-12 |
| CN1402710A (zh) | 2003-03-12 |
| SK7602002A3 (en) | 2003-02-04 |
| NO20022589L (no) | 2002-07-31 |
| CZ20021906A3 (cs) | 2003-02-12 |
| CA2392504A1 (fr) | 2001-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI991485L (fi) | Uusi farmaseuttinen koostumus | |
| NO20015175D0 (no) | Farmasöytisk sammensetning | |
| PT1242087E (pt) | Composicoes farmaceuticas | |
| EE200200281A (et) | Pikornaviirusevastased ühendid ja kompositsioonid, nende farmatseutilised kasutusalad ning ained nende sünteesiks | |
| ID27415A (id) | Komposisi farmaseutik | |
| EE200100594A (et) | Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel | |
| FR2775596B1 (fr) | Nouvelles compositions pharmaceutiques | |
| EE200000468A (et) | Ühendid, nende kasutamine ja farmatseutiline kompositsioon | |
| IS6304A (is) | Kínasólínefnasambönd og lyfjafræðilegar efnasamsetningar sem innihalda þau | |
| NO20005913D0 (no) | Legemiddelsammensetning | |
| EE200200487A (et) | Asetidiini derivaadid, nende valmistamismeetodid ja farmatseutiline kompositsioon | |
| EE200100684A (et) | Indalüülasendatud benseenkarboksamiidid, nende valmistamismeetod, kasutamine ja farmatseutilised kompositsioonid | |
| ATE407131T1 (de) | Substituierte bipiperidine -zwischenverbindungen und deren derivate | |
| FR2795324B1 (fr) | Compositions pharmaceutiques stabilisees | |
| DK1524266T3 (da) | Farmaceutisk sammensætning | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| ITMI982222A0 (it) | Composizioni farmaceutiche orali contenenti buprenorfina | |
| DE69925167D1 (de) | Hochwitterungsbeständige pulverlackzusammensetzung | |
| EE200200342A (et) | Asendatud 8-arüülkinoliinid, nende kasutamine, farmatseutiline kompositsioon ja prekursorühend | |
| DE69943245D1 (de) | Gaserzeugende zusammensetzung | |
| PT1239832E (pt) | Composicoes farmaceuticas | |
| HUP0203275A3 (en) | 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants | |
| PT1227817E (pt) | Composicao farmaceutica aquosa contendo ciclesonida | |
| FI4488U1 (fi) | Farmaseuttinen koostumus | |
| FR2779145B1 (fr) | Nouvelles compositions pharmaceutiques |